fashion -WSS

fashion

author：fashion 2025-09-06 03:28:40 - browse：84479

Illustration of a hospital with stacks of dollar bills on top – private equity coverage from STAT — Adobe

Private equity firms are rapidly buying their way into the U.S. health care system, and as they do, new research finds they tend to increase costs and may also harm quality.

A new BMJ systematic review rounded up 55 studies on the effects of private equity buyouts in health care globally to flesh out an overarching conclusion. The team of researchers found that private equity ownership generally means higher costs for patients, insurance companies, and government programs. The effects on quality were mixed, with more evidence showing that such financial investors degrade quality.

“This is really the first widespread snapshot of what the impacts of all these developments are,” said Alexander Borsa, a study author and doctoral candidate at Columbia University.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： White House touts steps to stem shortages of cancer treatments

explore

WSS

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Testing for cancer recurrence creates a new limbo for patients

Food makers tried to stack nutrition panel with preferred experts

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

White House touts steps to stem shortages of cancer treatments

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

explore

fashion

explore

23andMe had bad news about my health. I wish a person had delivered it

An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

United colonoscopy coverage change 'may cost lives,' doctors say

The pink breast cancer awareness ribbon needs a redesign

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Generate Biomedicines machine learning biotech raises $273M

At least 13 dead in Texas as scorching temps continue

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Emergency medicine has repudiated 'excited delirium.' Now what?

hotspot

New weight loss drugs vying to be the next Wegovy or Mounjaro

Medtronic CEO on promising devices for diabetes, hypertension

PEPFAR is under serious threat — and so is global health

Food makers tried to stack nutrition panel with preferred experts

Emergency medicine has repudiated 'excited delirium.' Now what?

Diverse clinical trials: Why aren’t we there yet?

explore

explore

leisure time

entertainment